Abstract
From simplified in vivo tests, authors set up a cartography of the sensitivity of Plasmodium falciparum to amino-4-quinolines in Cameroon; they also evaluated the clinical and parasitological efficacy of different therapeutic protocols which make use of amino-4-quinolines, quinine, mefloquine and halofantrine. All these drugs are administered orally. They recommend maintaining home medication with chloroquine at the dose of 25 mg/kg over 3 days, conserving quinine for use in the case of a possible failure. The use of most recent antimalarials can be proposed only as a last resort.
MeSH terms
-
Administration, Oral
-
Aminoquinolines / administration & dosage
-
Aminoquinolines / pharmacology
-
Aminoquinolines / therapeutic use*
-
Amodiaquine / administration & dosage
-
Amodiaquine / pharmacology
-
Amodiaquine / therapeutic use
-
Animals
-
Antimalarials / administration & dosage
-
Antimalarials / pharmacology
-
Antimalarials / therapeutic use*
-
Cameroon
-
Child
-
Child, Preschool
-
Chloroquine / administration & dosage
-
Chloroquine / pharmacology
-
Chloroquine / therapeutic use
-
Drug Resistance
-
Humans
-
Malaria, Falciparum / drug therapy*
-
Mefloquine / administration & dosage
-
Mefloquine / pharmacology
-
Mefloquine / therapeutic use
-
Phenanthrenes / administration & dosage
-
Phenanthrenes / pharmacology
-
Phenanthrenes / therapeutic use
-
Plasmodium falciparum / drug effects*
-
Quinine / administration & dosage
-
Quinine / pharmacology
-
Quinine / therapeutic use
Substances
-
Aminoquinolines
-
Antimalarials
-
Phenanthrenes
-
Amodiaquine
-
Chloroquine
-
Quinine
-
halofantrine
-
Mefloquine